Contact
searchSearch
HMP Global

Respiratory Syncytial Virus News

News
RSV Pneumonia Leads to Elevated ICU Admissions and Mortality in Older Adults
08/08/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus...
08/08/2025
Pharmacy Learning Network
News
Comorbidities Drive ICU Admission and Mortality in RSV and HMPV Among Older Adults
07/16/2025
Grace Taylor, MS, MA
A Colorado study reveals distinct comorbidity-driven risks for ICU admission and mortality in older adults hospitalized with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV).]
A Colorado study reveals distinct comorbidity-driven risks for ICU admission and mortality in older adults hospitalized with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV).]
A Colorado study reveals...
07/16/2025
Pharmacy Learning Network
News
New RSV Vaccines Prove Effective in Older Veterans, VA Reports
07/08/2025
Grace Taylor, MS, MA
A study by the US Department of Veterans Affairs reveals that newly approved respiratory syncytial virus (RSV) vaccines significantly reduce infections and hospitalizations among veterans aged 60 and older.
A study by the US Department of Veterans Affairs reveals that newly approved respiratory syncytial virus (RSV) vaccines significantly reduce infections and hospitalizations among veterans aged 60 and older.
A study by the US Department of...
07/08/2025
Pharmacy Learning Network
News
RSV Vaccines Modestly Reduced Hospitalizations Among Older Adults in Local Study
06/16/2025
Grace Taylor, MS, MA
An analytical model study from King County, Washington, shows that respiratory syncytial virus (RSV) immunizations helped reduce hospitalizations among older adults during the 2023-2024 season.
An analytical model study from King County, Washington, shows that respiratory syncytial virus (RSV) immunizations helped reduce hospitalizations among older adults during the 2023-2024 season.
An analytical model study from...
06/16/2025
Pharmacy Learning Network
News
Multiple-Specimen Testing More Than Doubles RSV Detection in Hospitalized Adults
06/09/2025
Grace Taylor, MS, MA
The use of multiple specimen types more than doubles respiratory syncytial virus (RSV) detection rates in hospitalized adults compared to standard nasopharyngeal swabs, according to a study published in the Journal of Infectious Diseases.
The use of multiple specimen types more than doubles respiratory syncytial virus (RSV) detection rates in hospitalized adults compared to standard nasopharyngeal swabs, according to a study published in the Journal of Infectious Diseases.
The use of multiple specimen...
06/09/2025
Pharmacy Learning Network
News
Awareness and Access Gaps Hinder Uptake of RSV Vaccine Among Older Adults
05/20/2025
Grace Taylor, MS, MA
Despite the rollout of the first RSV vaccines for older adults, a new study finds that lack of awareness and access significantly limited uptake during the 2023-2024 season.
Despite the rollout of the first RSV vaccines for older adults, a new study finds that lack of awareness and access significantly limited uptake during the 2023-2024 season.
Despite the rollout of the first...
05/20/2025
Pharmacy Learning Network
News
RSV Vaccines Effective for Seniors With Small Increased Guillain-Barré Risk
05/13/2025
Grace Taylor, MS, MA
Research finds respiratory syncytial virus (RSV) vaccines offer strong protection for older adults, while highlighting a small but significant risk of Guillain-Barré syndrome.
Research finds respiratory syncytial virus (RSV) vaccines offer strong protection for older adults, while highlighting a small but significant risk of Guillain-Barré syndrome.
Research finds respiratory...
05/13/2025
Pharmacy Learning Network
News
Single-Dose RSV Vaccine Shows Sustained Protection in Older Adults
04/30/2025
Grace Taylor, MS, MA
A single dose of the RSVPreF3 OA vaccine provides lasting protection against RSV-related lung disease in older adults for up to three seasons, new trial results show.
A single dose of the RSVPreF3 OA vaccine provides lasting protection against RSV-related lung disease in older adults for up to three seasons, new trial results show.
A single dose of the RSVPreF3 OA...
04/30/2025
Pharmacy Learning Network
News
Self-Collected Oral-Nasal Swabs Fall Short for Detecting Influenza and RSV
04/29/2025
Grace Taylor, MS, MA
Self-swabbing for respiratory viruses may offer convenience but could come at the cost of missed diagnoses, a new study finds.
Self-swabbing for respiratory viruses may offer convenience but could come at the cost of missed diagnoses, a new study finds.
Self-swabbing for respiratory...
04/29/2025
Pharmacy Learning Network
News
Study Finds RSV Positivity Not Linked to Higher Mortality in Adults With Acute Respiratory Illness
03/17/2025
Grace Taylor, MS, MA
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for...
03/17/2025
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
David T. Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Paul Schulz, MD
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
Ronald Vender, MD, FRCPC
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
Abigail Cline, MD, PhD
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; Ryan Nix, BS, NRP, NCI
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Videos
Diabetes - Guideline Changes, Adherence, and Newer Drug Issues
09/15/2015
09/15/2015
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use